Stay ahead with today’s top stock market updates! RBI has denied IREDA’s equity request for a Nepal project, while Gensol promoters sold 2.37% equity to reinvest in the business. Lupin launched Rivaroxaban tablets in the US, and Tata Power signed a ₹49,000 crore MoU for 7,000 MW renewable projects in Andhra Pradesh. Shilpa Medicare’s Raichur unit received a USFDA observation, and Shiv Nadar transferred 47% of his HCL Corp stake to Roshni Nadar Malhotra. Bodal Chemicals will benefit from new anti-dumping duties on imports from China and Japan. Stay tuned for more market insights!
first published: Mar 10, 2025 08:47 am
A collection of the most-viewed Moneycontrol videos.
Live: Can Nifty reclaim 26,000 after RS 7.5 lakh crore selloff? | IndiGo in focus | Opening Bell
Live: Sensex, Nifty fall 1% amidst broad-based selloff | Closing Bell
Live: Can Nifty reclaim record levels as investors await FOMC decision this week? | Opening Bell
Why This Tenant Says Bandra Is Better Than California | The Tenant
